Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

3.7K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.7K
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

5.2K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
5.2K
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

8.1K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
8.1K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

147
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
147
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

85
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
85
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

410
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
410

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Cleaning validation in pharmaceutical quality control laboratories: a structured protocol for contamination risk mitigation.

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences·2025
Same author

Optimal designs for efficacy-toxicity response in dose finding studies using the bivariate probit model.

Computers in biology and medicine·2025
Same author

Optimum designs for clinical trials in personalized medicine when response variance depends on treatment.

Journal of biopharmaceutical statistics·2024
Same author

Modeling the Batch Sedimentation of Calcium Carbonate Particles in Laboratory Experiments-A Systematic Approach.

Materials (Basel, Switzerland)·2023
Same author

Randomizing a clinical trial in neuro-degenerative disease.

Contemporary clinical trials communications·2023
Same author

On the Design of Aqueous Emulsions of Colophony Resin.

Polymers·2023
Same journal

Acknowledgment of Referees 2025.

Biometrics·2026
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
関連記事をすべて見る

関連する実験動画

Updated: Sep 9, 2025

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
20:24

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study

Published on: January 31, 2014

16.6K

ドス・レスポンス・モデルのモデル・ロバストデザイン

Belmiro P M Duarte1,2,3, Anthony C Atkinson4, Nuno M C Oliveira3

  • 1Departamento de Engenharia Química e Biológica, Instituto Superior de Engenharia de Coimbra, Rua Pedro Nunes, Quinta da Nora, 3030-199 Coimbra, Portugal.

Biometrics
|August 28, 2025
PubMed
まとめ
この要約は機械生成です。

真のモデルが不明の実験を設計するには モデル・ロバスト・デザインのアプローチが必要です この研究では,データ収集の効率を向上させる最適な堅牢な実験設計のためのセミデフィニット・プログラミングの配列を提示しています.

キーワード:
D最適度基準ローター の 堅固さ の 基準半決まったプログラミングドス・レスポンスモデルモデル 頑丈なデザイン

さらに関連する動画

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.9K
Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays
06:13

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

6.7K

関連する実験動画

Last Updated: Sep 9, 2025

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
20:24

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study

Published on: January 31, 2014

16.6K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.9K
Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays
06:13

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

6.7K

科学分野:

  • 統計について
  • 実験的な設計
  • 数学モデリング

背景:

  • 最適な実験デザインは,通常,既知のモデル構造を想定します.
  • 投与反応モデリングのような分野ではよく見られるモデル不確実性は,単一の仮定モデルに基づけば,非効率的な実験計画につながる可能性があります.
  • モデルの堅牢な設計は,この不確実性の影響を軽減することを目的としています.

研究 の 目的:

  • 最適なモデルを体系的に開発する.
  • 基礎となるモデルが不確実な場合,実験設計を選択するという課題に取り組む.
  • 実験を設計するためのフレームワークを提供する 可能性のあるモデルのプール.

主な方法:

  • モデル・ロバスト・デザインのための3つの半定義プログラミング (SDP) ベースの公式を開発した.
  • 問題の構想のための強度基準の半定義表現性を活用した.
  • 異なるモデルにおける情報測定の比較性を確保するために,標準化された設計を採用した.
  • 候補プール内の非線形モデルに対応する,局所的に最適な設計に焦点を当てた.

主要な成果:

  • 最適なモデルの堅牢な実験設計のための新しいSDP製法を提示しました.
  • 7つの候補モデルを用いた用量反応研究を用いて,アプローチの適用性を実証した.
  • 標準化されたデザインが,クロスモデル情報測定の比較をいかに容易にするかを示した.

結論:

  • 提案されたSDPベースのアプローチは,モデルの堅牢な実験設計を構築するための体系的な方法を提供します.
  • この方法論は,モデルの不確実性がある場合のデータ収集の効率と適切さを高めます.
  • このフレームワークは,複数の潜在的なモデルを用いた用量反応研究などにおいて特に有用である.